XML 77 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Statement of Consolidated Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows From Operating Activities    
Net income (loss) $ (57) $ (149)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Gains on asset sales, net (22) (32)
Depreciation, depletion and amortization 1,536 1,350
Exploratory dry hole costs 10 132
Exploration lease and other impairment 14 28
Pension settlement loss 88 0
Stock compensation expense 66 53
Noncash (gains) losses on commodity derivatives, net 87 134
Provision (benefit) for deferred income taxes and other tax accruals (5) (28)
Loss on debt extinguishment 0 53
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (129) (247)
(Increase) decrease in inventories (44) (35)
Increase (decrease) in accounts payable and accrued liabilities (127) (140)
Increase (decrease) in taxes payable 22 9
Changes in other operating assets and liabilities (83) (70)
Net cash provided by (used in) operating activities 1,356 1,058
Cash Flows From Investing Activities    
Additions to property, plant and equipment - E&P (1,720) (1,265)
Additions to property, plant and equipment - Midstream (284) (168)
Payments for Midstream equity investments (33) (67)
Proceeds from asset sales, net of cash sold 22 607
Other, net (3) (8)
Net cash provided by (used in) investing activities (2,018) (901)
Cash Flows From Financing Activities    
Net borrowings (repayments) of debt with maturities of 90 days or less 176 0
Debt with maturities of greater than 90 days – Repayments (8) (610)
Payments on finance lease obligations (47) 0
Common stock acquired and retired (25) (1,120)
Cash dividends paid (241) (262)
Noncontrolling interests, net (41) (36)
Other, net 17 28
Net cash provided by (used in) financing activities (169) (2,000)
Net Increase (Decrease) in Cash and Cash Equivalents (831) (1,843)
Cash and Cash Equivalents at Beginning of Year 2,694 4,847
Cash and Cash Equivalents at End of Period $ 1,863 $ 3,004